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Stimulation of inducer T  lymphocytes to undergo clonal expansion and differ- 
entiation requires recognition of nominal antigen in the context of polymorphic 
determinants of class II major histocompatibility complex (MHC) 1 glycoproteins 
(Ia) displayed on specialized accessory cells (for review, see 1). Effective stimula- 
tion requires  both an ill-defined "processing" of native antigen (2-6),  perhaps 
corresponding to partial intracellular proteolysis and membrane reexpression of 
antigenic peptides, and the action of poorly characterized "lymphokines" (2, 4), 
possibly including, but not limited to, interleukin  1 (IL-1) (7).  A  more precise 
understanding of T  cell antigen recognition thus requires greater knowledge of 
the structural features of the interacting components, i.e., the T  cell receptor, 
Ia molecule, and immunogenic peptide, and more information about the addi- 
tional  membrane and soluble components involved in turning the recognition 
event into complete T  cell activation. 
Substantial progress has recently been made in each of these areas.  Detailed 
analyses of the minimal stimulatory peptide(s) of protein antigens has been carried 
out in several laboratories (6, 8-10).  A  two-chain polypeptide structure for the 
antigen receptor of MHC-restricted T  cells has been demonstrated (11-14) and 
a  gene encoding one of these peptides has been cloned (15,  16).  Finally,  the 
molecular cloning of class II genes of mouse and man has provided a relatively 
complete picture of the primary structure of these glycoproteins and identified 
the major site of intraspecies polymorphism as  the amino-terminal domain of 
both a  and/3 chains (reviewed in 17). 
The availability of these cloned Ia genes has permitted the initiation of studies 
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using  DNA-mediated  gene  transfer  to  dissect  further  the  structure-function 
relationship of Ia molecules to T  cell antigen recognition.  Our initial work in 
this area (18) first demonstrated that such transfected Ia genes are functionally 
expressed by Ia  + B cell lymphomas known to be capable of accessory cell activity, 
and revealed  that  the  polymorphism between  Aa chains alone is  sufficient to 
create a  "restriction element" for at least some T  cells. To derive a model system 
that (a) permitted complete control of the a and/3 chains available for Ia assembly, 
and (b) might permit dissecting the recognition of (antigen plus Ia) from subse- 
quent activation steps, we have chosen to transfect Ia genes into a  fibroblastoid 
cell line of murine origin. These Ia- L cells are not considered to be among the 
cell  types  typically capable  of direct  T  cell  stimulation.  The  present  report 
demonstrates, in agreement with the work of others (19,  20),  that such L  cells 
express the products of the transfected Ia genes on their surface, and describes 
the accessory cell activity of these cells in stimulating responses of a variety of T 
lymphocytes. 
Materials and Methods 
Mice.  C3H/HN mice were obtained from the Small  Animal Branch, NIH. C57BL/ 
10, B 10.A(4R), and B 10.A mice were obtained from the barrier-sustained colony at NIH 
or Sprague-Dawley, respectively. All animals were maintained on food and water ad lib, 
and used at 8-20 wk of age. 
Antigens.  L-glutamic acid6°-L-alanineS°-L-tyrosine  I° (GAT) was purchased from Vega 
Biochemicals, Tucson, AZ, and prepared as previously described (21). Pigeon cytochrome 
c (cyto c) cyanogen bromide cleavage fragment (1-65)  was prepared as described (22). 
Keyhole limpet hemocyanin (KLH) was obtained from Calbiochem-Behring Corp.,  La 
Joila, CA and hen egg lysozyme (HEL) was purchased from Sigma Chemical Co., St. 
Louis, MO. 
Media.  Dulbecco's modified Eagle's medium with 4,500 mg/i glucose (Gibco Labora- 
tories, Grand Island, NY) was supplemented with 2 mM L-glutamine, 10% fetal calf serum 
(FCS), and 20 ug/ml gentamyicin (DME-10). RPMI 1640 (Biofluids, Inc., Rockville, MD) 
was supplemented with 10% FCS, 5 X 10  -s M 2-mercaptoethanol, and 10 mM Hepes (R 
medium). A mixture of 50% RPMI 1640, 50% Eagle's high amino acid medium containing 
10% FCS, 5 X 10  -s 2-mercaptoethanol and 2 mM L-glutamine was termed ER. Interleukin 
2 (IL-2)-containing medium was either the supernatant of the EL-4 thymoma stimulated 
with 10 ng/mi phorbol myristic acetate (PMA) for 24 h or the supernatant of a 5 X 106 
celis/mi culture of rat splenocytes incubated with 5 #g/ml concanavalin A (Con A) for 24 
h. Selective medium for transfection experiments consisted of DME-10 plus hypoxanthine 
(15 ~g/ml), aminopterin (0.2 #g/ml), and thymidine (5 #g/ml) (HAT) (23), DME-10 plus 
mycophenolic acid (6 #g/ml), hypoxanthine (15 #g/ml), and xanthine (250 #g/ml) (MXH) 
(24), or a combination of the two (DME-10,  HAT, MXH). 
Cells.  All cultured cell lines used in these experiments, their origin, and properties, 
are described in Table I. The DAP.3 line of Ltk- cells (23) was grown in DME-10  and 
passaged by 1:10 subculture two times per week after trypsin-EDTA treatment. DAP.3 
and  all  L  cell  transfectants were  prepared  for  use  in  experiments  by trypsin-EDTA 
removal from the culture vessel, followed by washing and resuspension in FCS-containing 
medium. The M12.4.1  H-2  a B lymphoma (25),  the A20-2J H-2  a B lymphoma (26), the 
a/d  d  k  d  TA3 (H-2  X H-2 ) B cell hybridoma (25), the LK (H-2  x  H-2 ) B hybridoma (27), and 
the B cell transfectant T70.3.1 (H-2  d, Aa  k) (18) were all maintained by biweekly passage 
at 1:50 in R medium. T  hybridomas were maintained in the same manner in DME-10, 
except for C10,  which required  ER medium for growth.  The  IL-2-dependent, GAT- 
specific T cell clone 11.4 (31), generously provided by Dr. J. Ashwell, NIH, was maintained 
in ER medium with 5% IL-2-containing supernatant. The 4R.6 pigeon cyto c-specific T 
cell line, kindly provided by Dr. G. Suzuki, NIH, was maintained by stimulating 2 x  l0 s 1318  ANTIGEN  PRESENTATION  BY  IA-EXPRESSING  L  CELLS 
TAnLE  I 
Cell Lines Used in this Study 
Cell  Cell type  Reference 
Transfected  Endogenous  Expressed 
Group 1 
Group II 
Group Ill 
DAP.3 
T43.6 
T43.7 
D3.4 
T78.11.1 
M12.4.1 
T70.3.1 
A20.2J 
LK 
L (fihroblast)  None  None  None  23 
L transfectant  A~  k  None  None  This paper 
L transfectant  A~  None  None  This paper 
L transfectant  ApkA~  k  None  I-A  k  This paper 
L transfectant  AodAa  d  None  I-A  d  This paper 
B lymphoma  None  I-A  d, I-E  d  bA  d, I-E  d  25 
B transfeetant  Ap  k  I-A  a, I-E  d  A#  k, I-A  d, I-E  'j  18 
B lymphoma  None  I-A  d, bE  d  bA  d, I-E  d  '26 
B hybridoma  None  bA  d'k, I-E  d'k  I-A  d'k, I-E  d'k  27 
Antigen specificity  la restriction 
4R.6B  T  cell clone 
11.4  IL-2 dependent 
T  cell clone 
CTL-L  IL-2 dependent 
T  cell 
HT-2  1L-2 dependent 
T  cell 
Cytochrome c (1-65)  I-A  t  G. Suzuki, unpublished 
GAT  I-A  ~  31 
29 
30 
RF9.140  T  hybridoma  OAT  I-A  '~  28 
SKK9. I 1  T  hybridoma  KLH  I-A  k  J. Kappler & P. Marrack, 
unpublished 
SKK45.10  T  hybridoma  KLH  I-A  k  J. Kappler & P. Marrack, 
unpublished 
CI0  T  hybridoma  HEL  I-A  k  R. Schwartz, unpublished 
cells with  3  x  106  3,000  rad-irradiated  B10.A  spleen cells in  the presence of 0.5  #M 
pigeon cyto c cyanogen bromide fragment  1-65 for 7 d  in 2  ml in the wells  of 24-well 
cluster plates, then resting the cells on 3  x  106 irradiated B10 spleen cells for 2-3 wk. 
Viable cells were recovered using FicolI-Hypaque gradients and were washed before use. 
CTL-L and  HT-2 cells for IL-2 assay were maintained in  5%  rat Con A  supernatant. 
DAP.3 cells cotransfected with Ia genes plus the herpes thymidine kinase gene (TK) were 
selected (see below) and grown in DME-10, HAT. DAP.3 cells sequentially cotransfected 
with Aa  d plus TK, then A~  d plus pSV2gpt (see below), were first selected and grown using 
DME-10,  HAT, then DME-10, HAT, MXH. 
DNA Clones, Hybridization Probes, and Constructs.  Genomic clones of  Ae k,  AB  d,  Aa d, and 
k  A~  were isolated from ~ phage vectors or cosmid libraries. The isolation and nucleotide 
sequence of the Ae  k and  Aadgenes has been previously described (26,  32),  as has the 
construction in the plasmid vector pSV2gpt (24) of subclone pgI-Aak-gpt-1 containing an 
expressable  Aak gene (18). To prepare a vector with Aa  d, the original ~ phage clone of the 
d  t  A0  was  digested  with  BamHI  restriction  endonuclease  and  the  5  9.5  kilobase  (kb) 
fragment and  3'  2.3  kb fragments subcioned  into  the  BamHI site of pBR327.  These 
BamHI fragments were recovered from the plasmid subciones and ligated together into 
the BamH1 site of pSV2gpt. One such construct, containing the two fragments of the Aa  d 
gene in the proper orientation with respect to one another,  was identified and termed 
pgI-Aad-gpt-49. The A~  d gene used  in  these studies  was derived  from the  5'  BamHI/ 
EcoRI fragment of the A~  a gene, which is missing the end of the 3' untranslated region 
containing the poly A  addition signal (33),  and the  3' EcoRI/BamHI fragment of Aa  k, 
which  contains  such  a  signal  (32).  These  were  ligated  together  in  the  BamHI site of 
t  d  t  k  pSV2gpt,  generating  pg5 I-A~ 3 A a -gpt-1.  The  BamHI/EcoRI fragment  of A~  °  was 
kindly  provided  by  Dr.  Mark  Davis  from  a  cosmid  subclone  constructed  by  Dr.  M. 
Steinmetz (34).  The A~  k gene was isolated from a  subgenomic library prepared in  the 
HindIII cloning site of the X J 1 phage vector using a  7-10  kb fraction of HindIII-digested 
(H-2  k X H-2  a) DNA. The library was screened with A~d-coding region cDNA probe (35), NORCROSS  ET  AL.  1319 
made available to us by Dr.  M.  Davis. One of several phage clones hybridizing to this 
probe was isolated and the 9  kb HindlII insert containing the A~  k gene subcloned into 
the  HindIII site  of pBR327  to  generate  pgI-A~kA21.  The  identity  of this  clone  was 
confirmed  by  restriction  map  analysis  of  the  insert  DNA.  Hybridization  probe  for 
Northern blot analysis of RNA consisted of a Cfo fragment containing the 3'An  a cDNA 
described  in  (26).  All  recombinant  DNA  manipulations  were  carried  out  essentially 
according to Maniatis et al. (36). 
Transfection.  Cloned class II MHC genes were introduced into DAP.3 cells using the 
calcium phosphate coprecipitation method, as previously described for class I genes (23), 
48 h after transfection, stable transformants were selected by incubation in drug-contain- 
ing medium. T43.7  represents a  pool of cells from DAP.3 cotransfected with pBRTK 
plus  ~  phage  DNA  containing  Aa  a and  selected  in  DME-10,  HAT.  T43.7  cells were 
retransfected with DNA from pg5' I-A,~d3'A~k-gpt  - 1 and selected in DME- 10, HAT, MXH. 
Clones  growing  in  this  medium  were  screened  for  surface  I-A  a  expression  using  a 
modification of the polyester replica plating technique of Raetz et al. (37). Colonies were 
overlayed with polyester cloth and after 2 wk the filter was washed in phosphate-buffered 
saline (PBS),  incubated with MKD6 (anti-I-A  d) antibody (38),  washed, and incubated in 
~SI-goat anti-mouse IgG (New  England  Nuclear,  Boston,  MA).  The clone (T78.11.1) 
giving the strongest autoradiographic signal was picked and expanded. D3.4 was derived 
as a pool of cells growing in DME-10, HAT, after cotransfection of DAP.3 with pgI-An  k- 
gpt-1,  pgI-A~kA21,  and  pBRTK.  The  M12.4.1  BALB/c  B  lymphoma  transformant 
T70.3.1  expressing An  k was produced  using spheroplast fusion as previously described 
(18). 
Analysis  of Specific RNA  Transcripts.  Cytoplasmic RNA  was  prepared according to 
Mushinski et al. (39).  10 #g (for B cells) or 40 #g (for transfectants) of this RNA were 
applied in 2.2 M formaldehyde to 1% agarose gels containing 0.22 M formaldehyde, and 
subjected to electrophoresis for 600 volt hours. The RNA was transferred to nitrocellulose 
filters according to the method of Southern  (40),  hybridized  using s2p nick-translated 
probes, and autoradiographs were prepared as previously described (18). 
Monoclonal  Antibodies.  The monoclonal antibodies  used  in  these  experiments were 
k  k  d  10.2.16, anti-I-A  (Ia-m.27), specific for An  (41); MKD6, anti-I-A  (38);  M5/114, anti-I- 
d  d/k  k  A  , I-E  (42); and  11.4.1, anti-H-2K  (41). All monoclonai antibodies were in the form 
of cell-free sterile culture supernatants containing 5-50 #g/ml specific antibody. They 
were added as indicated at culture initiation to a final concentration of 12.5-25% (vol/ 
voi), or used as described below for fluorescent staining. 
Flow Cytometry.  Cell surface expression of Ia was assessed by microfluorimetric analysis 
on a  FACS II (B-D FACS Systems, Sunnyvale, CA). Cells (5  X  105) in 50 #l R medium 
were mixed with 50 #l of the appropriate monoclonal antibody supernatant in the wells 
of a  96-well microtiter plate. After 30 min on ice, the cells were washed twice in PBS, 
resuspended in 50 #l of R medium containing I #g of fluorescein isothiocyanate (FITC)- 
goat F(ab)'2 anti-mouse IgG (Cappel Laboratories, Cochranville, PA) and incubated for 
an additional 30 min on ice. Stained cells were washed and fixed in 1% paraformaldehyde 
in  PBS.  Profiles shown  indicate  log  fluorescence (channel  number)  on  the abcissa vs. 
percent of total cells on the ordinate. A total of 10,000 cells was analyzed for each profile. 
T Cell Assays.  Production of IL-2 by T cell hybridomas (38) was measured by culturing 
105 T  cell hybridoma cells with 5 x  104 to 105 antigen-presenting cells (APC) and antigen 
for 24 h in 200 ~l ER medium in 96-well microtiter trays (Falcon 3040; Falcon Labware, 
Oxnard, CA). Individual culture supernatants from triplicate cultures were collected and 
tested for IL-2 content at a  1:4 dilution on 4 ×  10 a cells of the IL-2-dependent cell line 
CTL-L or HT-2. 1 #Ci of [aH]thymidine ([aH]TdR) (6.7 Ci/mmoi; New England Nuclear) 
was added at 24 h  and the cultures harvested  16-20 h  later using an automated multi- 
sample harvester. Data are shown as counts per minute plus or minus standard error. 
Interaction of T  cell clones with  transfected cells was assayed by culturing  2  x  104 
rested  viable  4R.6  T  cells  with  either  12,000  rad-irradiated  B  cells or  18,000  rad- 
irradiated L cells, with or without 1 #M pigeon cyto c fragment (1-65). Cells were cultured 
for 76 h, then labeled for 20 h  with [SH]TdR and recovered for scintillation counting. 1320  ANTIGEN  PRESENTATION  BY  IA-EXPRESSING L  CELLS 
The GAT +  I-Ak-restricted, IL-2-dependent T  cell clone,  11.4, was washed before use 
and similarly tested except that antigen consisted of 100 #g/ml GAT (Vega Biocbemicals) 
and the cultures were harvested at 72 h. 
For mitogen responses, normal T  cells were prepared from C3H/HN mice (NIH) by 
passing ~ 100 x  108 lymph node cells over a nylon wool column. These were then used 
after treating 50 x  108 nylon-passed cells with anti-Ia antibody (10.2.16 [1:3], 1 ml; MS/ 
114 [ 1:3]) and  1 ml rabbit complement (1:6) (Low-Tox; Accurate Chemical & Scientific 
Corp., Westbury, NY) for 30 min at 37°C.  Ia- T  cells prepared in this manner lacked 
direct Con A responsiveness. T  cells were washed and cultured at 2.5 x  105 per well with 
104 irradiated stimulator cells for 96 h; [3H]TdR incorporation was assessed over the last 
20 h of culture. 
Photography.  Cultures in flat-bottomed microtiter plates were photographed on Kodak 
technical pan film 2415 with a Leitz inverted microscope using phase optics. 
Results 
Transcription of I-A Genes In L Cells.  We have previously shown (18) that the 
product of the Aa  k gene introduced into an I-Ad-bearing B cell tumor is expressed 
on  the  cell  surface  in  normal  amounts  and  functions  as  an  MHC  restriction 
element for T  cell stimulation. To ascertain whether the Ia- murine L cell would 
possess  accessory cell  function  in  T  cell  activation  assays  if it  bore  Ia  on  its 
membrane,  cloned  I-A  genes  were  introduced  into  L  cells  using  the  calcium 
phosphate precipitation technique. DNA from genomic clones of Aa  k or A¢  a in 
bacteriophage vectors, containing the entire gene plus several kilobases of 5' and 
3'  flanking  DNA,  was  cotransformed with  pBRTK  DNA  into  DAP.3  TK-  L 
cells.  Stable  transformants  growing  in  HAT-selective medium  were  shown  by 
Southern blot analysis  to contain  one to several copies of the cloned Aa genes 
(data not shown). To assess the transcriptional activity of these transfected genes, 
cytoplasmic RNA was prepared and analyzed by Northern blotting, using an A¢ 
3'  cDNA probe.  Fig.  1 shows that no Aa-specific mRNA  was detectable in the 
parental  DAP.3  cells (lane  1),  while T43.7  (lane 2), containing the transfected 
FIGURE  1.  Northern blot analysis of Aa-transfected cells. Cytoplasmic RNA (40 #g/lane for 
DAP.3 and T43.7, 10 #g/lane for A20-2J) was electrophoresed on 1% agarose formaldehyde 
gels. The RNA was transferred to nitrocellulose and hybridized with a nick-translated Aa 
cDNA probe, and the washed blot was subjected to autoradiography. NORCROSS  ET  AL.  1321 
A0  d gene, produced substantial amounts of Aa message. These autoradiograms 
show two  major species of hybridizing transfectant RNA,  at  1.3  and  1.1  kb, 
which are both present, although in strikingly different proportions,  in  B cell 
iymphoma RNA (lane 3). The amount of hybridizing RNA in transfected L cells 
vs.  B  lymphoma cells ranged from 30-50%  of the level of Aa message in the 
M12.4.1  tumor  line  to  10-20%  of the  level  in  the A20-2J  tumor  line.  It  is 
important to note that the transcriptional activity detected in these studies did 
not require either cotransformation with or covalent linkage to DNAs containing 
viral enhancer elements. 
Thus, L cells, which are constitutively Ia- and cannot be induced to express 
Ia using ~'-interferon-containing T  cell supernatants (unpublished observations), 
nonetheless transcribe exogenously introduced A~ genes,  including one  (At~  k) 
identical to that already present in their genome. 
Surface  Expression  of  I-A  by  L  Cells Possessing Transfected  A,  and  Aa 
Genes.  Analysis of the Ao L cell transfectants with monoclonal anti-I-A antibod- 
ies,  including  10.2.16  (which is  capable  of binding  isolated  Aa  k polypeptides) 
revealed no surface Ia expression. This result is consistent with previous data on 
the requirement for a/~ dimers for Ia surface expression (43), including recent 
studies with gene transfectants (19, 20). 
To  derive  cells potentially  able  to  express  surface  Ia,  the  T43.7  cell  was 
transfected with DNA from a recombinant clone (pg5'I-Aad3'Aak-gpt-1) contain- 
ing the entire coding region of A,,  d spliced to the 3' untranslated region of AO  k, 
which provides the poly A addition signal but no coding sequence. Selection in 
DME-10,  HAT,  MXH led to the growth of clones that were screened using a 
replica-plating method and cellular radioimmunoassay for surface I-A  d expres- 
sion,  as detected by the monoclonal antibody MKD6.  One clone identified in 
this manner, T78.11.1,  was chosen for further study. At the same time, DAP.3 
cells were cotransfected with At~  k (pgI-A~k-gpt  - 1), A~k(pgI-A~kA21), and pBRTK, 
and a  pool of cells surviving selection in  DME-10,  HAT was designated D3.4. 
Transcription of the introduced A, genes was evaluated by Northern blotting. 
Substantial  amounts  of A,  transcripts  (10-20%  the  level  observed  in  B  cell 
tumors) were seen in T78.11.1  and D3.4  RNA, while such hybridizing species 
were absent from DAP.3 or the A a alone transfectant T43.7. The A, transcripts 
in D3.4 transfected with A,  k co-migrated with B cell A, message at 1.4 kb. The 
A, transcripts derived from cells possessing the hybrid A,d:Aa  k gene show the 
expected increase in size, due to an additional 3'  untranslated sequence intro- 
duced  from  the  As  k  gene  segment,  as  well  as  a  larger  species  presumably 
representing the result of aberrant splicing secondary to creation of the hybrid 
gene (data not shown). 
These  A,:Aa  transfectants  were  analyzed  for  surface  expression  of  Ia  by 
staining with  monocional anti-I-A  d (MKD6)  or anti-I-A  k (10.2.16)  antibodies, 
followed by FITC-conjugated goat F(ab')~ anti-mouse IgG (Fig.  2).  Cells from 
A,k:Aa  k transfectant pool D3.4 stained only with 10.2.16, not with MKD6, while 
T78.11.1  cells stained with MKD6 but not  10.2.16.  T78.11.1  cells also stained 
with M5/114  (anti-I-Ad), and D3.4 cells stained with 39J  (anti-I-A,  k) (data not 
shown). Thus, the transfected L cells not only transcribed both A, and A s, but 
expressed the translated products of these mRNAs on the cell membrane. The 1
.
 
O
0
 
p
 
O
.
 
8
0
 
e
 
e
 
0
.
 
6
0
 
P
 
O
.
 
4
0
 
n
 
0
.
 
2
0
 
0
,
 
O
0
 
1
.
0
0
.
 
D
3
.
4
 
"
 
.
.
.
.
 
~
'
0
 
.
.
.
.
 
*
b
0
 
C
h
a
n
n
e
l
 
n
u
m
b
e
r
 
M
1
2
.
4
.
1
 
-
 
-
 
"
 
,
o
o
b
 
p
 
O
.
 
8
0
'
 
e
 
r
 
O
.
 
6
0
 
r
 
~
t
 
O
.
 
4
0
 
o
 
n
 
7
 
O
.
 
2
0
 
"
I
 
"
,
 
I
 
.
.
:
t
~
 
'
.
,
t
 
,
I
 
,
I
 
.
I
 
,
t
 
•
 
/
 
'
l
 
"
f
 
'
.
l
 
.
'
f
l
 
,
 
t
 
'
)
 
e
 
*
L
 
/
,
:
~
*
 
"
.
!
~
 
0
.
0
o
 
'
"
 
"
 
"
 
.
.
.
.
.
 
1
0
 
.
.
.
.
.
.
 
1
0
0
 
"
"
 
"
 
"
 
~
0
0
0
 
C
h
a
n
n
e
l
 
n
u
m
b
e
r
 
F
I
G
U
R
E
 
2
.
 
S
u
r
f
a
c
e
 
l
a
 
e
x
p
r
e
s
s
i
o
n
 
b
y
 
t
r
a
n
s
f
e
c
t
e
d
 
L
 
c
e
l
l
s
•
 
C
e
l
l
s
 
w
e
r
e
 
s
t
a
i
n
e
d
 
w
i
t
h
 
m
o
n
o
c
l
o
n
a
l
 
a
n
t
i
-
I
-
A
 
a
n
t
i
b
o
d
i
e
s
 
a
s
 
o
u
t
l
i
n
e
d
 
i
n
 
M
a
t
e
r
i
a
l
s
 
a
n
d
 
M
e
t
h
o
d
s
 
a
n
d
 
a
n
a
l
y
z
e
d
 
o
n
 
a
 
F
A
C
S
 
I
|
 
f
l
o
w
 
c
y
t
o
m
e
t
e
r
.
 
P
r
o
f
i
l
e
s
 
r
e
p
r
e
s
e
n
t
 
l
o
g
 
f
l
u
o
r
e
s
c
e
n
t
 
p
 
O
.
 
8
0
 
e
 
r
 
c
 
e
 
O
.
 
6
0
 
P
 
e
 
r
 
T
7
8
.
1
1
.
1
 
1
.
0
0
.
 
~
L
t
'
 
L
 
b
 
I
'
 
I
,
 
I
'
 
°
"
°
t
 
'
,
:
 
I
 
,
 
/
 
C
h
o
n
n
e
 
J
 
n
u
m
b
e
r
 
1
.
0
0
.
 
T
7
0
.
3
.
1
 
•
 
P
e
e
r
 
O
.
 
B
O
 
;
~
d
/
~
!
l
 
O
.
 
6
0
 
O
.
 
4
0
 
T
 
0
2
0
 
.
 
/
 
o
.
 
o
o
 
'
"
 
"
 
-
~
6
 
.
.
.
.
.
.
 
1
o
o
 
~
o
o
0
 
C
h
a
n
n
e
l
 
n
u
m
b
e
r
 
c
h
a
n
n
e
l
 
v
s
.
 
t
h
e
 
p
e
r
c
e
n
t
 
o
f
 
t
o
t
a
l
 
c
e
l
l
s
 
f
o
r
 
1
0
,
0
0
0
 
c
e
l
l
s
 
a
n
a
l
y
z
e
d
.
 
(
.
 
•
 
.
)
 
F
I
T
C
 
a
n
t
i
-
I
g
 
o
n
l
y
;
 
(
-
 
-
 
-
)
 
1
0
.
2
.
1
6
 
(
a
n
t
i
-
I
-
A
a
k
)
;
 
(
 
)
 
M
K
D
6
 
(
a
n
t
i
-
I
-
A
d
)
.
 
r
~
 
i
-
,
o
 
>
 
Z
 
-
4
 
Z
 
C
/
3
 
Z
 
-
4
 
>
 
-
4
 
Z
 
t
-
n
 
X
 
O
o
 
_
=
 
Z
 
C
~
 
c
3
 
t
-
 
t
-
 NORCROSS ET AL. 
TABLE II 
Stimulation ofT Cell Hybridomas by la-bearing L Cell Transfectants 
1323 
APC  Cell type 
la  Ashy hybridomas* 
SKKg.ll  SKK45.10  CI0  RF9.140 
Transfected  Endogenous  (KLH:I.Ak)  (KLH:I.Ak)  (HEL:I_At)  (GAT:I.Ad) 
Exp,  1 
LK  B hybridoma  None  I-A  da', I-E  d'k  19,300 4- 68  31,667 4- 401  35,957 ±  427  __t 
D3.4  L  transfectant  AakA~  None  18,142 ±  125  2,768 ±  275  1,885 ±  125  -- 
T70.3.1  B transfectant  Aj  k  I-A  d, I-E  d  654 4- 76  716 4- 6  1,085 4- 255  -- 
Exp. 2 
LK  B hybridoma  None  I-A  ~'k, I-E  d'~  --  --  --  88,394 ±  4,776 
T43.7  L transfectant  A¢  d  None  --  --  --  2,557 ±  279 
T78.11.1  L transfectant  AadAB  a  None  --  --  --  52,877 4- 4,194 
*  l0  s T  hybridoma cells were cultured with l0 s transfected L cells  or 5  x  10  s lymphoid APC and antigen for 24 h. Supernatants  from these 
cultures were assayed at a  1:4 dilution on HT-2 cells. The data are given as total  cpm 4- SE for [SH]TdR incorporation for triplicate cultures. 
Antigen concentrations:  KLH,  1 mg]ml; HEL, 200 #g/ml; and GAT, 500 p.g/ml. 
* Not tested. 
fluorescence profiles of both cell types are relatively homogeneous and indicate 
that they have  1/5 to  1/10 the total  amount of surface I-A expressed by the B 
lymphoma transfectant T70.3.1. 
Antigen  Presentation  to  T  Cell  Hybridomas  by  I-A-expressing  L  Cell  Transfee- 
tants.  The transcription,  translation, and surface expression of I-A by L  cells 
containing transfected Ia genes permitted us to investigate whether such normally 
Ia- cells, without known accessory cell activity, could replace physiologic acces- 
sory cells in tests of T  cell activation.  I-A-expressing, transfected L  cells were 
placed  in  culture  with  T  hybridomas in  the absence or  presence of specific 
antigen and IL-2 release into the culture medium was measured 24 h later. The 
data presented in Table II show that both of the transfectants tested presented 
antigen to at least one T  cell hybridoma. D3.4  cells (I-A  k positive) stimulated 
SKK9.11, a KLH-reactive, I-Ak-restricted T  hybridoma (Exp. 1). A second KLH- 
specific hybridoma (SKK45.10) responded weakly, while an HEL-specific hybri- 
doma assayed in this experiment did not respond to D3.4,  but did respond to 
the control B cell hybrid LK. This differential ability of D3.4 to stimulate I-A  k- 
restricted cells was seen in several similar experiments, and may reflect differ- 
ences between the responding T  cells in the quantitative level of Ia required for 
activation, variations in requirements for other elements lacking in the L  cell 
transfectants, or differential requirements for antigen processing. These issues 
are currently under further investigation. SKK9.11,  which responded to D3.4 
cells expressing A~k:Aa  k, failed to be stimulated by the B lymphoma transfectant 
T70.3.1, which expresses Aa  k without A~  k. This suggests that SKK9.11  requires 
the specific A~  k chain as part of its "restriction element", and that it may require 
the  A~k:A,  k  dimer  for  this  purpose.  The  I-Ad-bearing  T78.11.1  line  could 
consistently  stimulate  the  GAT-specific,  I-Ad-restricted  hybridoma  RF9.140, 
which was not triggered by the Aoa-only transfectant T43.7 (Table II, Exp. 2). 
The I-Ak-bearing D3.4 cells did not stimulate RF9. I40 in the presence of GAT, 
nor did the I-Aa-bearing T78.11.1 cells activate the SKK9.11 cells in the presence 
of KLH (data not shown). 
To substantiate further that the L  cell transfectants were stimulating the T 
cell hybridomas by virtue of the Ia  molecules expressed on their membranes, 1324  ANTIGEN  PRESENTATION  BY  IA-EXPRESSING  L  CELLS 
monoclonal anti-Ia antibodies were used to inhibit the responses. Antigen pres- 
entation to these T  hybridomas was specifically blocked by antibodies that bound 
to the surface-expressed products of the transfected Ia genes (Table III). Exper- 
iment 1 shows that antigen presentation to the GAT-specific hybridoma RF9.140 
was inhibited by the anti-I-A  d antibodies MKD6 and M5/114, whereas 10.2.16 
(anti-I-Ak), which does not bind to T78.11.1, or 11.4.1, which binds to the class 
I K k molecule, have no effect. On the other hand, accessory cell function of D3.4 
cells was only blocked by 10.2.16.  These data establish the specific involvement 
of I-A  expressed  by  genes  transfected  into  L  cells  in  the antigen-presenting 
activity of these cells. 
Since the L cell transfectants express 5-10-fold less I-A than antigen-presenting 
B cell tumors, it might be expected from previous work showing a relationship 
between level of Ia expression and T  cell stimulation (44) that there would be 
quantitative differences in antigen-presentation by B lymphomas vs. transfected 
L cells. These expected differences wele observed in both the cell and antigen 
dose response patterns of RF9.140  to B lymphomas vs. T78.11.1,  as shown in 
Figs. 3 and 4. Fig. 3 illustrates the dose response to varying cell numbers in the 
presence of a  fixed antigen concentration, and  Fig.  4  shows the relationship 
between antigen concentration and  response at a  fixed cell number.  In both 
titrations,  the  T78.11.1  cells  were  less  efficient than  B  iymphoma  cells  in 
stimulating RF9.140,  requiring more cells or antigen for comparable levels of 
IL-2 release. 
Antigen Presentation to T Cell Clones by I-A-expressing L Cell Transfectants.  The 
above results indicate that L cells bearing surface I-A molecules can effectively 
take  up  and  present  complex  antigens  to  I-A-restricted  T  cell  hybridomas. 
Experiments were next undertaken to explore whether these same transfectants 
could present antigen to, and activate, long-term T  cell clones, which may have 
different physiologic requirements for stimulation compared with T hybridomas. 
The T  cell clone 4R.6 is specific for pigeon cyto c fragment (1-65) in the context 
of I-A  k, and it is maintained by repetitive stimulation and rest. As shown in Table 
IV, this T  cell responds to D3.4 (I-A  k) cells in the presence of antigen, but fails 
to proliferate in the presence of antigen together with either T78.11.1  (I-A  d) or 
T70.3.1  (A0  k) transfectants. (The high background seen with L cell transfectants 
is due to the extreme radioresistance of these cells, which continue to incorporate 
[3H]TdR even after exposure to  18,000  rad.) The response to D3.4 could be 
specifically blocked with anti-I-A  k monoclonal antibody.  These data,  together 
with the absence of a  response by 4R.6  cells to L  cells bearing the I-A of the 
wrong haplotype, even in the presence of antigen, and the failure of D3.4 cells 
to stimulate without antigen, indicate that the observed T cell responses required 
recognition of I-A on the L cells. 
Tests  of a  second  T  cell  clone gave  different results.  The  clone  11.4  was 
maintained in the presence of Con A supernatant without any feeder cells. The 
effect of mixing this cloned T  cell line with various transfectants and antigen is 
detailed in Table V, experiment 1. Although these T cells proliferated to antigen 
plus  the  A0k-bearing  B  lymphoma  transfectant  T70.3.1,  they  failed  to 
proliferate in  response to the irradiated,  I-Ak-bearing D3.4  cells plus antigen. 
Rather, such experiments consistently showed a decrease in the background level T
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Cell  Number/Culture 
FXGURE 3.  APC dose responses for the GAT-responsive T  cell hybridoma, RF9.140.  105 
RF9-]40 were incubated with 200 #g/mi of GAT and various numbers of the B lymphoma 
M12.4.1, the I-A  a transfectant T78.11.1, or the A~e-transfected L cell T43.7. Data are shown 
as [SH]TdR incorporation (cpm =l= SE) of CTL-L cells in response to a  1:4 dilution of culture 
supernatant from the stimulated T  hybridoma. 
M12.4.1 (I-A  d) 
8°  I  I  I  I 
70  A20.2J (I.A  d  ) 
A  6O 
% 
~6O 
o 
g 
a 
3O 
~3O 
78.11.1 (A~dAa  d) / 
,o 
0  25  50  100  200  500 
Antigen  Concentration  (~g/ml) 
FIGURE 4.  Antigen dose response of RF9.]40 with various APC.  ]05  RF9.]40 cells were 
cultured  with  either  5  x  104  B  lymphoma cells or  10 ~ transfected L  cells and  various 
concentrations of GAT. Supernatants from 24-h cultures were assayed as in Fig. 3. 
of [SH]TdR  incorporated  by the transfectants,  which was most pronounced in 
the presence of antigen.  This inhibitory effect on D3.4  was reversed by anti-I- 
A k but not anti-I-A d antibody. Experiment 2 was carried out using unirradiated 
transfected  cells, and  shows identical results on the  I-A k L  cells and a  similar, 
though lesser, effect on the B lymphoma transfectant line. T
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TABLE  VI 
Accessory Cell Function of L Cells  for T Cell Mitogen Responses 
Accessory 
cell*  Transfected la  No addition  Tcell  ConA  ConA+ 10.2.16  Con A +  M5/114 
None  --  ND*  465 4. 27  1,596 4- 468  ND  ND 
T43.6  A¢  k  28,613 4- 285  13,454-4- 1,403  188,511  4. 13,228  156,847  + 5.477  178,924 4. 17,458 
T78.11.1  AedA,,  d  20,310 4. 605  13,644  4- 612  298,000 4- 8,014  161,994  4- 2,872  240,250 4- 13,294 
D3.4  A#kA,,  t  15,422+602  10,3324.74  200,111  +7,292  197,3554. 19,270  179,155+ 13,187 
DAP.3  None  984 4. 92  176,754  "," 33,379 
* Purified la-negative T  cells (2.5  x  l0  s) prepared as in Table V were cultured with  104 irradiated L cells with and without Con A (5/~g/ml). 
Antibody supernatants were added to a final concentration  of 25%.  [SH]TdR  incorporation was assayed over the last 20 h of a 96 h culture 
period. Data are presented as total cpm 4. SE. 
~: Not done. 
This impression of an antigen- and I-A-specific cytotoxic effect by  11.4 cells 
was confirmed by direct observation. As shown in Fig. 5, cultures containing L 
cell transfectants plus T  cells, but without antigen, showed well-spread L  cells 
interspersed randomly among T  cells, a  few of which are associated with the 
transfected cells (Fig. 5A). Upon the addition of antigen, large clusters of T  cells 
formed on the I-A  g (but not I-Ad)-bearing cells (Fig. 5B). Transfected cells visible 
in such cultures had the appearance of damaged cells. Monoclonal antibody to 
I-A  k reversed the clustering and the cytopathic effect (Fig. 5 C). Such cytopathic 
changes were not seen in cultures of transfected cells and the 4R.6 clone. These 
experiments indicate that in the complete absence of feeder cell contamination, 
L cell transfectants bearing the appropriate I-A can, in the presence of antigen, 
cause specific changes in the activity of a cloned, nonmalignant T  cell line. Taken 
together with the data on the 4R.6 clone, these results show that I-A-bearing L 
cells  provide  the  accessory  cell  functions  necessary  for  the  restimulation  of 
previously activated "memory" T  cells. 
Effects of  L Cells and L Cell Transfectants in Mitogen Responses.  One of the best 
characterized models of Ia-bearing accessory cell function is the mitogen response 
to lectins such as Con A. Experiments were therefore carried out to explore the 
ability of Ia-bearing L cell transfectants to replace normal Ia  ÷ accessory cells in 
this primary stimulation model. Lymph node cells from C3H mice were passed 
through nylon wool and treated  with monoclonal anti-Ia  plus complement to 
remove endogenous accessory cells. As shown in Table VI, such purified T  cells 
failed to respond to Con A  directly, as previously reported (45, 46).  However, 
the addition of L cells, irrespective of their expression of Ia, equally reconstituted 
the response to this mitogen. These findings document the ability of L cells to 
function as accessory cells in a primary T  cell response, but disagree with earlier 
results showing a requirement for Ia on accessory cells in this system. Ia per se 
is apparently not required for accessory cell activity in the Con A response. 
Discussion 
The overall purpose of the experiments described above was to devise a model 
system capable of producing sets of cells, one member totally Ia negative, the 
others expressing only those Ia gene products experimentally introduced into 
the  parent  (Ia-)  cell  type.  Such  a  system  would  permit  examination  of  the 
regulation of Ia gene transcription and translation, as well as the assembly and NORCROSS  ET  AL.  1331 
cell surface expression of these gene products.  Cells expressing membrane Ia 
could be tested for their ability to stimulate various T  lymphocytes, providing, 
via the use of in vitro generated Ia gene variants, a  method for correlating Ia 
gene structure with function. Finally, it was possible that an uncoupling ofT cell 
Ia recognition from subsequent activation steps might be observed, allowing a 
more precise analysis of the cofactors required in the postrecognition phase of 
T  cell stimulation. 
The results presented here demonstrate that most of these desired features 
can be achieved using DNA-mediated gene transfer to introduce full-length Ia 
genomic clones into mouse Ltk- cells. These cells are constitutively Ia- and do 
not express  Ia after exposure to 3~-interferon-containing culture supernatants 
(M. Norcross, unpublished observations). The introduction of As  k or Aft genes 
carried on X phage vectors as a  CaPO4 coprecipitate with pBRTK DNA led to 
the production of cell lines that had stably incorporated these genes into chro- 
mosomal DNA.  Further, such cells actively transcribed the transfected genes, 
producing mRNA of the same size as Ia-expressing B cell tumors. This transcrip- 
tion occurred even though in the case of As  k the identical gene present in the 
Ltk- cells is inactive.  These data indicate that  the lack of As transcription  in 
DAP.3 cells is not caused by a  trans-acting repressor mechanism. Our findings 
are consistent with results recently published by Rabourdin-Combe and Mach 
(19),  who demonstrated the transcription of genomic clones of human class  II 
genes in  mouse L  cells after transfection. These observations differ from the 
results of Malissen et al. (20), who failed to see expression of AS  k and Aa  k after 
transfection, unless DNA containing strong viral enhancer/promoter elements 
was used for cotransformation.  It  is  possible  in  these latter experiments that 
transcription  did occur without the added enhancer elements, but  generated 
very few clones with sufficient expression to register in  their assay. Our own 
studies with L  cells containing class  II genes linked to strong viral promoter- 
enhancer elements are consistent with this interpretation, as we find 5-10-fold 
increases in  Ia  mRNA and protein levels in  such cells (Germain, unpublished 
observations). Surface expression of Ia required the presence of both As and A~ 
genes.  Again,  such  results  confirm  both  earlier studies  on  Ia  expression  by 
normal lymphoreticular cells (43),  and recent gene transfection studies using 
human or murine genes (19, 20). The present studies do not address the role of 
invariant chain (47), which has been identified in L cells (48), in Ia membrane 
expression. 
The Ia molecules expressed by the transfected L cells were recognized nor- 
mally by the small  panel of anti-Ia monoclonal antibodies used in  this study. 
Additional antibodies will need to be tested to determine if all known serological 
specificities assigned to I-A  k or I-A  d are expressed by the transfectants. It is also 
important to determine if the heterogeneity of Ia molecules observed in immu- 
noprecipitation  experiments by  some investigators  using normal  cells will  be 
found also with these L cells (49). 
The  major  focus  of the  present  study  was  the  functional  activity  of  Ia- 
expressing L cell transfectants in T  cell stimulation assays. Both I-Ad-bearing and 
I-Ak-bearing transfectants were able to cause IL-2 production by T  cell hybri- 
domas in an antigen-specific, MHC-restricted manner in experiments using both 1332  ANTIGEN  PRESENTATION  BY  IA-EXPRESSING  L  CELLS 
polypeptide and complex protein antigens. These results confirm and extend the 
report of Malissen et al. (50) showing that an I-Ak-bearing L cell could present 
the antigen KLH to several T  hybridomas. The studies by Chestnut et al. (5), 
Shimonkevitz et al.  (6),  and  Ziegler and  Unanue (3)  have demonstrated that 
antigen presentation of such molecules to T  cells involves at least two distinct 
steps: (a) the processing of the native antigen, which is believed to involve partial 
lysosomal proteolysis, and (b) the display on the cell surface of processed antigen 
along with Ia. The present data suggest that L cells may be capable of processing 
antigen in a manner similar to normal accessory cells. However, direct testing of 
this presumption is needed to rule out the possibility that the L cells somehow 
circumvent the processing requirement, or that the particular hybridomas used 
respond to unprocessed antigen. Recent experiments indicate that I-Ak-bearing 
L cells can present antigen to a hybridoma previously shown to require stimula- 
tion by processed antigen (R. Lechler and R. Germain, unpublished observation). 
Additional tests of the accessory cell potential of the Ia transfectants involved 
nonmalignant T  cells maintained in  long-term cultures. These previously acti- 
vated T  cells also demonstrated antigen-dependent, I-A-restricted interactions 
with the transfected L cells. The 4R.6 cytochrome fragment (1-65)-specific clone 
proliferated in response to antigen plus the D3.4  (I-A  k) cell line, but failed to 
respond to  D3.4 alone, or to T78.11.1  (LA  d) with or without antigen.  These 
findings essentially rule out the possibility that functional I-Ak-bearing feeder 
cells were carried over into the assay culture, and, in the presence of nonspecific 
factors  from  the  L  cells,  acted  as  APC.  The  findings  do  not  eliminate  the 
potential contribution of nonspecific factors by residual feeder cells that permit 
the L  cells to fully trigger the T  cell clone. Tests of the  11.4 clone, which is 
carried in  IL-2-containing medium without feeder cells,  revealed an antigen- 
specific, MHC-restricted cytotoxic effect. This activity establishes that such T 
cells can recognize antigen and  Ia on the L  cell surface.  With  respect to  the 
observed cytotoxicity itself,  several points can be made. First,  L  cells are the 
major cell type used over the years in assays of T  ceil-derived lymphotoxin (51). 
Although preliminary experiments have failed to demonstrate a soluble cytotoxin 
in  culture  supernatants  of  11.4  cells  stimulated  with  antigen  and  D3.4,  this 
mechanism cannot be ruled out. Second, the activity does not appear to be due 
to 11.4 actually being an Ia-specific cytotoxic T  lymphocyte, since, at moderate 
effector to target ratios, little chromium release is seen from labeled D3.4 cells 
after 18-24 h (M. Norcross, unpublished observations). Lastly, the finding that 
B  cell tumors were also subject to a  cytopathic effect under these conditions 
raises the possibility that we are observing a physiologic mechanism involved in 
homeostatic control of immunity. T  cells may inactivate accessory cells and some 
B cells after interacting with them to reduce further immune stimulation. 
There is an extensive literature on the cofactor requirements for full stimula- 
tion  of T  cell responses by accessory cells (reviewed in  52).  In general, these 
studies have shown a requirement for IL-1  or other unspecified soluble media- 
tors, in addition to the display of Ia. The ability of Ia-bearing L cells to serve as 
accessory cells in a variety of T  cell responses needs to be assessed in this light. 
L cells have long been known to produce one or more growth factors, particularly 
colony-stimulating factor  (CSF)  (53),  and  L  cell  supernatants  are  a  standard NORCROSS  ET  AL.  1333 
source of conditioned medium for augmenting growth of other cell types. If the 
partially activated T  cell lines require any cofactors, such mediators or adequate 
substitutes may be produced by the transfected L cells. The constitutive elabo- 
ration of such materials might also explain the ability of both Ia- and Ia  + L cells 
to act as accessory cells in mitogen responses. The Ia  ÷ cell requirement for such 
function seen in earlier studies may relate to the possibility that only Ia  + cells 
normally can produce the required cofactors (54), and that Ia recognition is not 
required by the T  cell itself, if the requisite soluble mediators are present. 
Taken together, these results indicate that transfection of Ia genes into L cells 
will  be  a  powerful  tool  for  dissection  of the  role  of Ia  in  immunity.  The 
experiments  can  control  the  precise  mix  of I-A  or  I-E  subregion  elements 
expressed by the cell, and introduce in  vitro generated variant genes without 
needing to account for the effects of endogenous class II gene expression. The 
resultant cells function in a  variety of T  cell assays suitable for analysis of the 
regions of Ia that are recognized by the T  cell receptor(s) and should provide a 
means for examining the  relationship  between immunogen and  Ia  structure 
underlying restricted antigen recognition. 
Summary 
To study the relationship between the structure and function of Ia antigens, 
as well as the physiologic requirements for antigen presentation to major histo- 
compatibility complex-restricted T  cells, class II Aa and Aa genes from the k 
and d  haplotypes were transfected into Ltk- fibroblasts using the calcium phos- 
phate  coprecipitation  technique.  Individually transfected genes  were actively 
transcribed in the L cells without covalent linkage to, or cotransformation with, 
viral  enhancer sequences.  However, cell surface expression of detectable I-A 
required the presence of transfected A~dAa  d or AakAa  k pairs in a single cell. The 
level of I-A expression under these conditions was 1/5-1/10 that of Ia  + B lymphoma 
cells, or B lymphoma cells expressing transfected class II genes. 
These 1-A-expressing transfectants were tested for accessory cell function and 
shown to present polypeptide and complex protein antigens to T  cell clones and 
hybridomas in the context of the transfected gene products. One T  cell clone, 
restricted to  I-A  k plus  GAT  (L-glutamic acid6°-L-alanineS°-L-tyrosinel°), had a 
profound cytotoxic effect on I-A  k- but not I-Ad-expressing transfectants in the 
presence of specific antigen. Assays of unprimed T  cells showed that both Ia  ÷ 
and  Ia-  L  cells  could  serve  as  accessory cells  for  concanavalin  A-induced 
proliferative responses. These data indicate that L cells can transcribe, translate, 
and express transfected class II genes and that such I-A-bearing L cells possess 
the necessary metabolic mechanisms for presenting these antigens to T  lympho- 
cytes in the context of their I-A molecules. 
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